Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Alpha Lipoic Acid for the Reduction of Treatment Related Pain and Side Effects During Chemoradiation in Patients with Stage II-IVB Head and Neck Squamous Cell Cancer

Trial Status: administratively complete

This phase I trial studies the side effects and best dose of alpha lipoic acid in decreasing treatment related pain and side effects during chemoradiation in patients with stage II-IVB head and neck squamous cell cancer. Alpha lipoic acid has been used effectively to increase pain tolerance for diabetic and other nerve pain. Alpha lipoic acid may alleviate pain and improve the quality of life in patients with head and neck squamous cell cancer while undergoing chemoradiation.